NCT05978193 Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma Status RECRUITING Phase PHASE2
NCT05975749 Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer Status RECRUITING Phase PHASE2
NCT05939661 A Multicenter Single-arm P2 to Evaluate Safety and Efficacy of the Total Neoadjuvant Therapy for cT2 Rectal Cancer Status RECRUITING Phase PHASE2
NCT05935579 Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer Status RECRUITING Phase PHASE2
NCT05935098 BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors Status TERMINATED Phase PHASE1
NCT05926492 A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma Status RECRUITING Phase PHASE2
NCT05926427 Orelabrutinib Combined With Rituximab and Chemotherapy for Relapsed/Refractory B-Cell Lymphoma Patients With Central Nervous System Involvement Status RECRUITING Phase PHASE2
NCT05916755 Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform Status RECRUITING Phase N/A
NCT05909332 Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) Status RECRUITING Phase PHASE3
NCT05862610 The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC Status NOT_YET_RECRUITING Phase PHASE2
NCT05826964 Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05780372 Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05763199 Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05755672 On-treatment Biomarkers in Metastatic Colorectal Cancer for Life Status RECRUITING Phase N/A
NCT05731947 Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT05723107 EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC) Status RECRUITING Phase PHASE1
NCT05718466 Stereotactic Radiology Versus Chemotherapy for Recurrent/Progressive Glioblastoma After Second-Line Chemotherapy Status COMPLETED Phase PHASE3